Trial
NCT03132584
Cyclophosphamide and Alemtuzumab In Lymphoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Genzyme, a Sanofi Company; Sanofi
Condition
Non Hodgkin Lymphoma
Intervention
Cyclophosphamide
Why stopped
slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-01-14